LOGO-Atom Therapeutics (R) REV_500px
  • Home
  • About Atom
    • Management Team
    • Advisory Board
    • Investors
  • Our Programs
    • Pipeline
    • Gout & Hyperuricemia
    • Acute Gout
  • News & Events
  • Contact Us

Post navigation

Previous PostBioSpace: Atom Bioscience Doses First Patient in Phase 2b/3 Clinical Trial of a New Treatment for Chronic Gout
Next PostEndpoints: Atom Bioscience raises $83M in Series D for URAT1 inhibitor in chronic gout treatment

Follow us on

  • Home
  • About Atom
  • Our Programs
  • News & Events
  • Contact Us
©2024 Atom Therapeutics Co., Ltd